Previous 10 | Next 10 |
For income investors, closed-end funds, or CEFs, are an attractive investment class that offers high income generally in the range of 6%-10%, broad diversification in terms of a variety of asset classes, and market matching total returns in the long term if selected carefully and acquired at r...
The Weekly Closed-End Fund Roundup will be put out at the start of each week to summarize recent price movements in closed-end fund [CEF] sectors in the last week, as well as to highlight recently concluded or upcoming corporate actions on CEFs, such as tender offers. Most of the information h...
Faced with pushback from multiple fronts over high drug prices, biopharmaceutical firms are experimenting with new ways to get paid for their priciest offerings, mostly biologics, in a report from the WSJ. More news on: Alnylam Pharmaceuticals, Inc., Sanofi, Novartis AG, Healthcare stock...
The new budget proposed by California Governor Gavin Newsom includes a plan to allow the state to contract with generic drug makers to provide medicines to all Californians. He believes that the government's purchasing power may be sufficient to cut drug prices to the state's 40M residents...
Results from a new study showed that end-of-year drug approvals by the FDA are linked to more hospitalizations, life-threatening events and deaths, a rate about twice as high as medicines approved earlier in the year. More news on: ProShares Trust - ProShares Ultra Nasdaq Biotechnology,...
Fine-Tuning My Thoughts “If you can’t write about it, you haven’t really thought about it. This is why every year Warren [Buffett] sits down and writes a long letter to his shareholders explaining the past year’s events. This exercise has helped him immensely to ...
Reuters reports that pharmaceutical companies, including Pfizer (NYSE: PFE ), GlaxoSmithKline (NYSE: GSK ) and Sanofi (NASDAQ: SNY ), are planning to raise prices on more than 200 medicines in the U.S. tomorrow. More news on: Pfizer Inc., GlaxoSmithKline plc, Sanofi, Healthcare stocks ne...
For income investors, closed-end funds, or CEFs, are an attractive investment class that offers high income generally in the range of 6%-10%, broad diversification in terms of a variety of asset classes, and market matching total returns in the long term if selected carefully and acquired at r...
Author's note : This article was released to CEF/ETF Income Laboratory members on December 3, 2019. The Weekly Closed-End Fund Roundup will be put out at the start of each week to summarize recent price movements in closed-end fund ((CEF)) sectors in the last week, as well as to highl...
Co-produced by Stanford Chemist . This article was originally published on November 23, 2019. We previously covered the topic of analyzing fixed-income and preferred stock distribution sustainability. Looking at NII trends and interest rate impacts to gauge the continuation of a rate. W...
News, Short Squeeze, Breakout and More Instantly...
Blackrock Health Sciences Trust Company Name:
BME Stock Symbol:
NYSE Market:
Blackrock Health Sciences Trust Website:
2024-07-10 03:12:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
The BlackRock closed-end funds (the “Funds”) listed below announced today the results of the Quarterly Measurement Period (as defined below) under their previously announced discount management programs (the “Programs”). Funds with a Trigger Event (as defined below) at...
2024-06-20 05:18:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...